Expertise in
5
conditions

Deliang X. Fu

12 Wulumuqi Middle Road, 
Shanghai, CN 
Expertise in
5
conditions
12 Wulumuqi Middle Road, 
Shanghai, CN 

Overview

Deliang Fu practices practicing medicine in Shanghai, China.

Fu is highly rated in 5 conditions, according to our data. Their clinical expertise encompasses Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Gastrointestinal Fistula, Pancreaticoduodenectomy, and Pancreatectomy.

They are actively involved in clinical research, co-authoring 103 peer reviewed articles and participating in 1 clinical trial.

Locations

12 Wulumuqi Middle Road, Shanghai, 200040, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Prospective, Randomized, Controlled, Double-blind, Multi-center Clinical Study of Nimotuzumab Combinated With Gemcitabine Contrast to Placebo Combinated With Gemcitabine in K-RAS Wild-type,Locally Advanced and Metastatic Pancreatic Cancer
A Prospective, Randomized, Controlled, Double-blind, Multi-center Clinical Study of Nimotuzumab Combinated With Gemcitabine Contrast to Placebo Combinated With Gemcitabine in K-RAS Wild-type,Locally Advanced and Metastatic Pancreatic Cancer
Enrollment Status: Completed
Publish Date: April 04, 2024
Intervention Type: Drug, Other
Study Drugs: Nimotuzumab, Gemcitabine
Study Phase: Phase 3

103 Total Publications

HRD Score: A Promising Biomarker for Genomic Instability Evaluation for Targeted Treatments Among Pancreatic Cancer Patients.
HRD Score: A Promising Biomarker for Genomic Instability Evaluation for Targeted Treatments Among Pancreatic Cancer Patients.
Journal: Technology in cancer research & treatment
Published: July 14, 2026

Frequently Asked Questions about Deliang X. Fu

Is Deliang X. Fu a top-rated expert for Pancreatic Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Deliang X. Fu is classified as an Distinguished expert for Pancreatic Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Deliang X. Fu participate in research or clinical trials?

Yes. Deliang X. Fu has published 103 articles and abstracts on conditions like Pancreatic Cancer. You can view a list of Deliang X. Fu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Fu's expertise for a condition
ConditionClose
    View All 13 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile